Kelyniam Global, Inc. (KLYG)

Market Cap	5.94M -37.8%
Revenue (ttm)	2.67M -11.4%
Net Income	-218.47K
EPS	-0.01
Shares Out	50.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,584
Open	0.10495
Previous Close	n/a
Day's Range	0.10495 - 0.1198
52-Week Range	0.0910 - 0.3000
Beta	0.54
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 16, 2026

About Kelyniam Global

Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial implant for patients requiring the reconstruction of cranial and facial structures. It serves surgeons, health systems, and payors. The company was formerly known as Ketner Global Investments, Inc. and ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 20
• Stock Exchange: OTCMKTS
• Ticker Symbol: KLYG

Financial Performance

In 2023, Kelyniam Global's revenue was $2.67 million, a decrease of -11.44% compared to the previous year's $3.02 million. Losses were -$218,471, 123.9% more than in 2022.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 10, 2026

Data Sources Report a data error